Expertise in
68
conditions

Dr. John E. Poulos

Gastroenterology
Fayetteville Gastroenterology Associates P.A.
2041 Valleygate Dr, 
Fayetteville, NC 
Accepting New Patients
Offers Telehealth
Expertise in
68
conditions
Fayetteville Gastroenterology Associates P.A.
2041 Valleygate Dr, 
Fayetteville, NC 

Overview

John Poulos is a Gastroenterologist practicing medicine in Fayetteville, North Carolina.

Dr. Poulos is highly rated in 68 conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Juvenile Polyposis Syndrome, Attenuated Familial Adenomatous Polyposis, Gastrectomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 7 peer reviewed articles and participating in 7 clinical trials. Dr. Poulos is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in NC

Hospital Affiliations

Cape Fear Valley Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Fayetteville Gastroenterology Associates P.A.
2041 Valleygate Dr, Fayetteville, NC 28304

Additional Areas of Focus

Dr. Poulos has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Enrollment Status: Terminated
Publish Date: June 30, 2026
Intervention Type: Drug
Study Drug: Belapectin
Study Phase: Phase 2/Phase 3
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AXA1665 in Subjects With Liver Cirrhosis and Prior Overt Hepatic Encephalopathy (EMMPOWER)
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AXA1665 in Subjects With Liver Cirrhosis and Prior Overt Hepatic Encephalopathy (EMMPOWER)
Enrollment Status: Terminated
Publish Date: July 27, 2022
Intervention Type: Drug
Study Drug: AXA1665
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
Enrollment Status: Completed
Publish Date: September 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

7 Total Publications

Detection of Potential MetALD and ALD Using Phosphatidylethanol in a Large Multicenter MASH Trial Screening Cohort.
Detection of Potential MetALD and ALD Using Phosphatidylethanol in a Large Multicenter MASH Trial Screening Cohort.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 30, 2025
Similar Doctors
Expertise in
18
conditions
Dr. Evan S. Dellon
Gastroenterology
Expertise in
18
conditions
Dr. Evan S. Dellon
Gastroenterology
Referral may be required

UNC Hospitals Pulmonary Function Lab

101 Manning Dr, 
Chapel Hill, NC 
 (60.3 miles away)
919-966-5787
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Evan Dellon is a Gastroenterologist practicing medicine in Chapel Hill, North Carolina. Dr. Dellon is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Eosinophilic Esophagitis, Esophagitis, Eosinophilic Enteropathy, Endoscopy, and Colonoscopy. Dr. Dellon is currently accepting new patients.

Expertise in
15
conditions
Dr. Nicholas J. Shaheen
Gastroenterology
Expertise in
15
conditions
Dr. Nicholas J. Shaheen
Gastroenterology
Referral may be required

UNC Hospitals Pulmonary Function Lab

101 Manning Dr, 
Chapel Hill, NC 
 (60.3 miles away)
984-974-5050
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nicholas Shaheen is a Gastroenterologist practicing medicine in Chapel Hill, North Carolina. Dr. Shaheen is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Barrett Esophagus, Esophagitis, Gastroesophageal Reflux Disease (GERD), Endoscopy, and Tissue Biopsy. Dr. Shaheen is currently accepting new patients.

Expertise in
67
conditions
Dr. Arvind S. Kumar
Gastroenterology
Expertise in
67
conditions
Dr. Arvind S. Kumar
Gastroenterology
Referral may be required

Fayetteville Gastroenterology Associates P.A.

2041 Valleygate Dr, 
Fayetteville, NC 
 (0.1 miles away)
910-323-5203
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Arvind Kumar is a Gastroenterologist practicing medicine in Fayetteville, North Carolina. Dr. Kumar is highly rated in 67 conditions, according to our data. His clinical expertise encompasses Attenuated Familial Adenomatous Polyposis, Cronkhite-Canada Disease, Juvenile Polyposis Syndrome, Gastrectomy, and Endoscopy. Dr. Kumar is currently accepting new patients.

Frequently Asked Questions about Dr. John E. Poulos

How do I make an appointment with Dr. John E. Poulos?

You can book an appointment with Dr. John E. Poulos by calling their office at 910-323-5203. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John E. Poulos a top-rated expert for Non-Alcoholic Fatty Liver Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John E. Poulos is classified as an Distinguished expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John E. Poulos specialize in?

While Dr. John E. Poulos is a Gastroenterology, they have specific expertise in Non-Alcoholic Fatty Liver Disease, Juvenile Polyposis Syndrome, and Attenuated Familial Adenomatous Polyposis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. John E. Poulos participate in research or clinical trials?

Yes. Dr. John E. Poulos has published 7 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Dr. John E. Poulos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. John E. Poulos accept my insurance?

Dr. John E. Poulos accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 910-323-5203 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Poulos's expertise for a condition
ConditionClose
    View All 22 Distinguished Conditions
    View All 46 Advanced Conditions
    View All 49 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile